Hepatic steatosis: a risk factor for increased COVID-19 prevalence and severity-a computed tomography study
{{output}}
Background: Around 25% of the world population was affected by the metabolic-related fatty liver disorder. Hepatic steatosis is frequently observed in conjunction with hypertension, obesity comorbidities, and diabetes. We evaluat... ...
